Literature DB >> 6334694

Pneumocystis carinii antigenemia in adults with malignancy, infection, or pulmonary disease.

L L Pifer, H B Niell, B J Morrison, J D Counce, J M Freeman, D R Woods, C L Neely.   

Abstract

A counterimmunoelectrophoresis test for Pneumocystis carinii antigenemia was employed to assess the extent of subclinical infection or colonization with this agent in adults with infection, pulmonary disease, or malignancy and in healthy homosexual men. Antigenemia was detected in 6 of 208 (3%) of normal controls, 3 of 28 (11%) of patients with pulmonary infection, 3 of 33 (9%) of those with chronic lung disease, 1 of 36 (3%) of patients with lung cancer, 7 of 271 (3%) of afebrile subjects with malignancy, 6 of 19 (32%) of febrile patients with malignancy, 2 of 22 (9%) of those with nonpulmonary infection, and 0 of 21 (0%) of healthy young homosexual men. These data suggest that P. carinii is a common commensal or saprophyte that becomes clinically significant only when host defenses are impaired. Antigenemia may occur intermittently during various disease states in the absence of positive clinical signs and should alert the physician to subacute infection or colonization. Treatment appears advisable when clinical data and counterimmunoelectrophoresis results concur.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6334694      PMCID: PMC271467          DOI: 10.1128/jcm.20.5.887-890.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Pneumocystis carinii in children with malignant disease.

Authors:  M R Sedaghatian; D B Singer
Journal:  Cancer       Date:  1972-03       Impact factor: 6.860

2.  Pneumocystis carinii.

Authors:  W B Hamlin
Journal:  JAMA       Date:  1968-04-08       Impact factor: 56.272

3.  Propagation of Pneumocystis carinii in vitro.

Authors:  L L Pifer; W T Hughes; M J Murphy
Journal:  Pediatr Res       Date:  1977-04       Impact factor: 3.756

4.  Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis.

Authors:  W T Hughes; S Feldman; R J Aur; M S Verzosa; H O Hustu; J V Simone
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

5.  Parasitologic and serologic observations of infection with Pneumocystis in humans.

Authors:  J H Meuwissen; I Tauber; A D Leeuwenberg; P J Beckers; M Sieben
Journal:  J Infect Dis       Date:  1977-07       Impact factor: 5.226

6.  Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children.

Authors:  L L Pifer; W T Hughes; S Stagno; D Woods
Journal:  Pediatrics       Date:  1978-01       Impact factor: 7.124

7.  Pneumocystis carinii pneumonitis in young immunocompetent infants.

Authors:  S Stagno; L L Pifer; W T Hughes; D M Brasfield; R E Tiller
Journal:  Pediatrics       Date:  1980-07       Impact factor: 7.124

8.  The in vitro response of human lymphocytes to Pneumocystis carinii antigen.

Authors:  H G Herrod; W R Valenski; D R Woods; L L Pifer
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

9.  The value of Pneumocystis carinii antibody and antigen detection for diagnosis of Pneumocystis carinii pneumonia after marrow transplantation.

Authors:  J D Meyers; L L Pifer; G E Sale; E D Thomas
Journal:  Am Rev Respir Dis       Date:  1979-12

10.  Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: a prospective study.

Authors:  S Stagno; D M Brasfield; M B Brown; G H Cassell; L L Pifer; R J Whitley; R E Tiller
Journal:  Pediatrics       Date:  1981-09       Impact factor: 7.124

View more
  5 in total

Review 1.  Pneumocystis carinii, an opportunist in immunocompromised patients.

Authors:  M S Bartlett; J W Smith
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

2.  Pneumocystis carinii antigenemia in acquired immunodeficiency syndrome.

Authors:  L W Pifer; B L Wolf; J J Weems; D R Woods; C C Edwards; R E Joyner
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

3.  Production of monoclonal antibody against Pneumocystis carinii by using a hybrid of rat spleen and mouse myeloma cells.

Authors:  C H Lee; C D Bolinger; M S Bartlett; R B Kohler; C E Wilde; J W Smith
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

4.  Serological observations of Pneumocystis carinii infection in humans.

Authors:  K Tanabe; T Furuta; K Ueda; H Tanaka; K Shimada
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

Review 5.  A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.

Authors:  Liang Ma; Ousmane H Cissé; Joseph A Kovacs
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.